Enliven Therapeutics has appointed Kristine Ball to its Board of Directors to leverage her extensive biopharmaceutical leadership experience as the company prepares to start a pivotal Phase 3 trial of relcobatinib for chronic myeloid leukemia by the end of 2026. Ball's expertise in transitioning companies from clinical development to commercialization is expected to support Enliven's growth and readiness for market launch. This move aligns with Enliven's strategy to develop innovative treatments and create shareholder value while advancing relcobatinib through late-stage clinical development.
Enliven Therapeutics' recent board appointment coincides with a Health sector where 90 of 150 US stocks rose today. For readers following this sector, here is Pluang's market snapshot as of Oct 15, 2026 03:02 WIB: Liquidia Corporation (LQDA) surged 26.45% to USD 33.90 with a typical hold time of 0 days and a buy order activity of 62%, MiniMed Group (MMED) declined 9.18% to USD 16.71 with a typical hold time of 6 days, and Alumis Inc. (ALMS) dropped 7.39% to USD 6.08 but saw 100% buy order activity and a 0-day typical hold time.
Lakefront Biotherapeutics has completed the sale of its preclinical CAR-T cell therapy programs to Belgium-based Armed Cell Therapeutics. The deal includes an upfront payment of €8 million, potential milestone payments up to $230 million, and a low s...
PNC Financial Services Group is set to report its Q3 2026 earnings with analysts forecasting earnings of around $4.91 per share and revenue near $6.61 billion, reflecting solid growth. The bank anticipates a 3%–3.5% rise in net interest income and 1%...
Leonardo DRS secured a 10-year prime contract under NASA's SEWP VI program, enabling federal agencies to quickly procure its defense products and services until 2036. This contract extends DRS's role as a SEWP prime contractor, supporting key militar...
Honey Badger Silver announced promising assay results from its first exploration program at the Yava Project in Nunavut, revealing high-grade silver, copper, gold, zinc, and lead samples. This marks the first systematic work at Yava in nearly two dec...
The 12th Annual Minneapolis C-Level Technology Leadership Summit will take place on October 27 at Interlachen Country Club, Edina, bringing together senior technology executives from leading Minnesota organizations like Cargill, Land O’Lakes, and Blu...
